Protalix BioTherapeutics
D

PLX

2.47000
USD
-0.08
(-2.95%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
-
P/E
11
حجم السوق
199,011,956
أصول ذات صلة

العنوان: Protalix BioTherapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.